{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:14:48Z","timestamp":1783606488384,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-026-01803-3","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:54:09Z","timestamp":1783583649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel eco-friendly spectrophotometric determination of potential combination silodosin and darifenacin hydrobromide in bulk and pharmaceutical formulations"],"prefix":"10.1186","volume":"20","author":[{"given":"Islam M.","family":"Darwish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M","family":"El-Abassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Bahgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"1803_CR1","unstructured":"Newer Medications for Lower Urinary Tract Symptoms (LUTS). Associated with Benign Prostatic Hyperplasia (BPH) | Effective Health Care (EHC) Program (Accessed April 9, 2025). https:\/\/effectivehealthcare.ahrq.gov\/products\/prostatic-hyperplasia-medications\/research-protocol."},{"key":"1803_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/J.AJUR.2017.05.003","volume":"4","author":"FF Vasanwala","year":"2017","unstructured":"Vasanwala FF, Wong MYC, Ho HSS, Foo KT. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians. Asian J Urol. 2017;4:181. https:\/\/doi.org\/10.1016\/J.AJUR.2017.05.003.","journal-title":"Asian J Urol"},{"key":"1803_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/S11884-013-0178-7","volume":"8","author":"K Giannitsas","year":"2013","unstructured":"Giannitsas K, Athanasopoulos A. Current Understanding of the Interplay between Oab & Bph. Curr Bladder Dysfunct Rep. 2013;8:128\u201333. https:\/\/doi.org\/10.1007\/S11884-013-0178-7.","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"1803_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, Wilt TJ. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023. J Urol. 2024;211:11\u20139. https:\/\/doi.org\/10.1097\/JU.0000000000003698.","journal-title":"J Urol"},{"key":"1803_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1592\/PHCO.30.12.1303","volume":"30","author":"H Lepor","year":"2010","unstructured":"Lepor H, Hill LA. Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability. Pharmacotherapy. 2010;30:1303\u201312. https:\/\/doi.org\/10.1592\/PHCO.30.12.1303.","journal-title":"Pharmacotherapy"},{"key":"1803_CR6","unstructured":"The Japanese Pharmacopoeia. Tokyo: Society of Japanese Pharmacopoeia: Distributed by Yakuji Nippo. 1996."},{"key":"1803_CR7","unstructured":"Silodosin | C25H32F3N3O4 | CID 5312125 - PubChem. (Accessed April 9, 2025). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Silodosin."},{"key":"1803_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2165\/00003088-200645040-00001","volume":"45","author":"A Skerjanec","year":"2006","unstructured":"Skerjanec A. The clinical pharmacokinetics of darifenacin. Clin Pharmacokinet. 2006;45:325\u201350. https:\/\/doi.org\/10.2165\/00003088-200645040-00001.","journal-title":"Clin Pharmacokinet"},{"key":"1803_CR9","unstructured":"Darifenacin Hydrobromide | C28H31BrN2O2 | CID 444030 - PubChem. (Accessed April 9, 2025). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Darifenacin-Hydrobromide."},{"key":"1803_CR10","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.18203\/2349-2902.isj20213989","volume":"8","author":"A Benedict","year":"2021","unstructured":"Benedict A, Rajenthiran V, Eswaramurthy A. Effects of silodosin, darifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Int Surg J. 2021;8:3031. https:\/\/doi.org\/10.18203\/2349-2902.isj20213989.","journal-title":"Int Surg J"},{"key":"1803_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00042307-200403000-00011","volume":"14","author":"BH Chew","year":"2004","unstructured":"Chew BH, Knudsen BE, Denstedt JD. The use of stents in contemporary urology. Curr Opin Urol. 2004;14:111\u20135. https:\/\/doi.org\/10.1097\/00042307-200403000-00011.","journal-title":"Curr Opin Urol"},{"key":"1803_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4155\/BIO-2017-0242","volume":"10","author":"PA Shah","year":"2018","unstructured":"Shah PA, Shrivastav PS. Novel LC-MS\/MS method for the quantification of silodosin and its metabolites in human plasma. Bioanalysis. 2018;10:7\u201310. https:\/\/doi.org\/10.4155\/BIO-2017-0242.","journal-title":"Bioanalysis"},{"key":"1803_CR13","doi-asserted-by":"publisher","unstructured":"Manoj Nair S, Kumar R, Sharma PM, Karia D. Development and Validation of High Performance LCMS Methods for Estimation of Silodosin and Silodosin \u03b2-D-Glucuronide in Human Plasma. Pharm Anal Chem. 2017;03. https:\/\/doi.org\/10.4172\/2471-2698.1000118.","DOI":"10.4172\/2471-2698.1000118"},{"key":"1803_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.18185\/ERZIFBED.955967","volume":"14","author":"ME YAMAN","year":"2021","unstructured":"YAMAN ME, AKMAN T\u00c7. Optimization of HPLC-FLD Conditions Using Analytical Quality by Design Approach for Quantification of Silodosin in Pharmaceutical Dosage Form. Erzincan \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi. 2021;14:993\u20131005. https:\/\/doi.org\/10.18185\/ERZIFBED.955967.","journal-title":"Erzincan \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi"},{"key":"1803_CR15","doi-asserted-by":"publisher","first-page":"109753","DOI":"10.1016\/J.MICROC.2023.109753","volume":"197","author":"M Wadie","year":"2024","unstructured":"Wadie M, Abdel-Moety EM, Rezk MR, Marzouk HM. A novel eco-friendly HPLC method with dual detection modes for versatile quantification of dutasteride and silodosin in pharmaceutical formulation, dissolution testing and spiked human plasma. Microchem J. 2024;197:109753. https:\/\/doi.org\/10.1016\/J.MICROC.2023.109753.","journal-title":"Microchem J"},{"key":"1803_CR16","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/JAOACINT\/QSZ045","volume":"103","author":"SA Boltia","year":"2020","unstructured":"Boltia SA, Abdelkawy M, Mohamed TA, Mostafa NN. Validated Chromatographic and Spectrofluorimetric Methods for Analysis of Silodosin: A Comparative Study with Application of RP-HPLC in the Kinetic Investigation of Silodosin Degradation. J AOAC Int. 2020;103:946\u201357. https:\/\/doi.org\/10.1093\/JAOACINT\/QSZ045.","journal-title":"J AOAC Int"},{"key":"1803_CR17","doi-asserted-by":"publisher","unstructured":"Lodha S, Pillai A, Kalyankar G, Dedhiya P, Joshi S, Shah S, Shah D. High-performance thin layer chromatographic method development and validation for simultaneous estimation of solifenacin succinate and silodosin using quality by design approach and greenness assessment. Sep Sci Plus. 2024;7. https:\/\/doi.org\/10.1002\/SSCP.202300178.","DOI":"10.1002\/SSCP.202300178"},{"key":"1803_CR18","doi-asserted-by":"publisher","unstructured":"Wadie M, Abdel-Moety EM, Rezk MR, Marzouk HM. Sustainable and smart HPTLC determination of silodosin and solifenacin using a constructed two illumination source chamber with a smartphone camera as a detector: Comparative study with conventional densitometric scanner. Sustain Chem Pharm. 2023;33. https:\/\/doi.org\/10.1016\/J.SCP.2023.101095.","DOI":"10.1016\/J.SCP.2023.101095"},{"key":"1803_CR19","unstructured":"Paljashuva K. Simultaneous Estimation Of Dutasteride And Silodosin In Bulk Form By RP-HPLC Method. World J Curr Med Pharm Res. n.d.;1:148\u201363. www.wjcmpr.com."},{"key":"1803_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.JPBA.2012.09.013","volume":"72","author":"MV Murthy","year":"2013","unstructured":"Murthy MV, Krishnaiah C, Srinivas K, Rao KS, Kumar NR, Mukkanti K. Development and validation of RP-UPLC method for the determination of darifenacin hydrobromide, its related compounds and its degradation products using design of experiments. J Pharm Biomed Anal. 2013;72:40\u201350. https:\/\/doi.org\/10.1016\/J.JPBA.2012.09.013.","journal-title":"J Pharm Biomed Anal"},{"key":"1803_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3126\/KUSET.V13I1.21251","volume":"13","author":"A Acharya","year":"2018","unstructured":"Acharya A, Satish NK, Manoj L, Chitti R. Development and validation of RP-HPLC method for the determination of Darifenacin Hydrobromide in bulk drug and pharmaceutical dosage form. Kathmandu Univ J Sci Eng Technol. 2018;13:36\u201344. https:\/\/doi.org\/10.3126\/KUSET.V13I1.21251.","journal-title":"Kathmandu Univ J Sci Eng Technol"},{"key":"1803_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/J.TALANTA.2013.10.037","volume":"121","author":"MM Hefnawy","year":"2014","unstructured":"Hefnawy MM, Alanazi AM, Abounassif MA, Mohammed MS, Attia SM, Mostafa GAE. Validated liquid chromatographic-fluorescence method for the quantitation of darifenacin in mice plasma and its application to a pharmacokinetic study. Talanta. 2014;121:37\u201342. https:\/\/doi.org\/10.1016\/J.TALANTA.2013.10.037.","journal-title":"Talanta"},{"key":"1803_CR23","unstructured":"Jvchrsty TS, Mathew BE. Development and validation of RP-HPLC method of analysis for the quantitative estimation of Darifenacin in tablet dosage forms, 5 (2012) 518\u201322."},{"key":"1803_CR24","doi-asserted-by":"publisher","first-page":"123650","DOI":"10.1016\/J.SAA.2023.123650","volume":"307","author":"Y Rostom","year":"2024","unstructured":"Rostom Y, Rezk MR, Wadie M, Abdel-Moety EM, Marzouk HM. State-of-the-art mathematically induced filtration approaches for smart spectrophotometric assessment of silodosin and solifenacin mixture in their new challenging formulation: Multi-tool greenness and whiteness evaluation. Spectrochim Acta Mol Biomol Spectrosc. 2024;307:123650. https:\/\/doi.org\/10.1016\/J.SAA.2023.123650.","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"key":"1803_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1134\/S1061934813090086","volume":"68","author":"LZ Meneghini","year":"2013","unstructured":"Meneghini LZ, Junqueira CA, Salazar FR, Brandalise M, Fr\u00f6ehlich PE, Bergold AM. Development and validation of a derivative ultraviolet spectrophotometric method for the determination of darifenacin in tablets using experimental designs and its comparison with chromatographic method. J Anal Chem. 2013;68:772\u201380. https:\/\/doi.org\/10.1134\/S1061934813090086.","journal-title":"J Anal Chem"},{"key":"1803_CR26","doi-asserted-by":"publisher","first-page":"01","DOI":"10.9790\/5736-0540109","volume":"5","author":"K Sayanna","year":"2013","unstructured":"Sayanna K, Venkateshwarlu G. Spectrophotometric Determination of Drugs and Pharmaceuticals by Cerium (IV) Amaranth Dye Couple. IOSR J Appl Chem. 2013;5:01\u20139. https:\/\/doi.org\/10.9790\/5736-0540109.","journal-title":"IOSR J Appl Chem"},{"key":"1803_CR27","unstructured":"Sridharan D, Thenmozhi U, Kumar L, Dutt A, Ramanaiah M, Phanikishore Y. Development and Validation of UV Spectrophotometric Method of Darifenacin Hydrobromide in Bulk and Tablet Dosage Form. Asian J Pharm Anal 1 (2011)."},{"key":"1803_CR28","first-page":"44","volume":"4","author":"S Praveen","year":"2011","unstructured":"Praveen S, Rao G, Jagathi V, Shaiba M, Babu CH. Spectroflourimetric method for the estimation of darifenacin in pure and pharmaceutical formulations. Asian J Pharm Clin Res. 2011;4:44\u20136.","journal-title":"Asian J Pharm Clin Res"},{"key":"1803_CR29","first-page":"195","volume":"26","author":"PS Praveen","year":"2010","unstructured":"Praveen PS, Jagathi V, Rao GD, Saibabu GS. Extractive Spectrophotometric Methods for the Determination of Darifenacin. Orient J Chem. 2010;26:195\u20137.","journal-title":"Orient J Chem"},{"key":"1803_CR30","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ELAN.202200085","volume":"34","author":"AS Abo Elalaa","year":"2022","unstructured":"Abo Elalaa AS, Abdel-Hamied Abdel-Tawab M, Abdel Ghani NT. El Nashar, Computational Design and Application of Molecularly Imprinted\/MWCNT Based Electrochemical Sensor for the Determination of Silodosin. Electroanalysis. 2022;34:1802\u201320. https:\/\/doi.org\/10.1002\/ELAN.202200085.","journal-title":"Electroanalysis"},{"key":"1803_CR31","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1039\/C7AY00992E","volume":"9","author":"E Er","year":"2017","unstructured":"Er E, \u00c7elikkan H, Erk N. An ultra-sensitive 2D electrochemical sensor based on a PtNPs@graphene\/Nafion nanocomposite for determination of \u03b11-AR antagonist silodosin in human plasma. Anal Methods. 2017;9:3782\u20139. https:\/\/doi.org\/10.1039\/C7AY00992E.","journal-title":"Anal Methods"},{"key":"1803_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/J.ELECTACTA.2015.01.020","volume":"157","author":"E Er","year":"2015","unstructured":"Er E, \u00c7elikkan H, Erk N, Aksu ML. A new generation electrochemical sensor based on Graphene nanosheets\/Gold nanoparticles\/Nafion nanocomposite for determination of Silodosin. Electrochim Acta. 2015;157:252\u20137. https:\/\/doi.org\/10.1016\/J.ELECTACTA.2015.01.020.","journal-title":"Electrochim Acta"},{"key":"1803_CR33","doi-asserted-by":"publisher","unstructured":"Wadie M, Abdel-Moety EM, Rezk MR, Mahmoud AM, Marzouk HM. Electro-polymerized poly-methyldopa as a novel synthetic mussel-inspired molecularly imprinted polymeric sensor for darifenacin: Computational and experimental study. Appl Mater Today. 2022;29. https:\/\/doi.org\/10.1016\/J.APMT.2022.101595.","DOI":"10.1016\/J.APMT.2022.101595"},{"key":"1803_CR34","doi-asserted-by":"publisher","first-page":"066512","DOI":"10.1149\/1945-7111\/AC77C2","volume":"169","author":"SD Al-Qahtani","year":"2022","unstructured":"Al-Qahtani SD, Hameed A, Alamrani NA, Alharbi A, Shah R, Al-Ahmed ZA, El-Metwaly NM. Zinc Oxide Nanostructured-Based Sensors for Anodic Stripping Voltammetric Determination of Darifenacin. J Electrochem Soc. 2022;169:066512. https:\/\/doi.org\/10.1149\/1945-7111\/AC77C2.","journal-title":"J Electrochem Soc"},{"key":"1803_CR35","unstructured":"ICH Q2 (R1.) Validation of Analytical Procedures: Text and Methodology, Geneva, 2005."},{"key":"1803_CR36","unstructured":"Hefnawy M. Initial-rate and fixed-kinetic spectrophotometric methods for determination of darifenacin hydrobromide in bulk and in its pharmaceutical preparation, 2016. https:\/\/www.researchgate.net\/publication\/301657392."},{"key":"1803_CR37","doi-asserted-by":"publisher","first-page":"100980","DOI":"10.1016\/j.scp.2023.100980","volume":"32","author":"HM Lotfy","year":"2023","unstructured":"Lotfy HM, Obaydo RH, Nessim CK. Spider chart and whiteness assessment of synergistic spectrophotometric strategy for quantification of triple combination recommended in seasonal influenza\u2013Detection of spurious drug. Sustain Chem Pharm. 2023;32:100980. https:\/\/doi.org\/10.1016\/j.scp.2023.100980.","journal-title":"Sustain Chem Pharm"},{"key":"1803_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mineng.2016.04.015","volume":"94","author":"Y Shen","year":"2016","unstructured":"Shen Y, Lo C, Nagaraj DR, Farinato R, Essenfeld A, Somasundaran P. Development of Greenness Index as an evaluation tool to assess reagents: Evaluation based on SDS (Safety Data Sheet) information. Min Eng. 2016;94:1\u20139. https:\/\/doi.org\/10.1016\/j.mineng.2016.04.015.","journal-title":"Min Eng"},{"key":"1803_CR39","doi-asserted-by":"publisher","unstructured":"Kayali Z, Obaydo RH, Sakur AA. Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation. Heliyon. 2023;9. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15260.","DOI":"10.1016\/j.heliyon.2023.e15260"},{"key":"1803_CR40","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1038\/s41467-021-24761-x","volume":"12","author":"C Larsen","year":"2021","unstructured":"Larsen C, Lundberg P, Tang S, R\u00e0fols-Rib\u00e9 J, Sandstr\u00f6m A, Mattias Lindh E, Wang J, Edman L. A tool for identifying green solvents for printed electronics. Nat Commun. 2021;12:4510. https:\/\/doi.org\/10.1038\/s41467-021-24761-x.","journal-title":"Nat Commun"},{"key":"1803_CR41","doi-asserted-by":"publisher","first-page":"100265","DOI":"10.1016\/j.greeac.2025.100265","volume":"13","author":"HM Hafez","year":"2025","unstructured":"Hafez HM, Mostafa AA, El-Abassy OM. Spider diagram with greenness assessment criteria for mathematical UV spectrophotometric methodologies for separating overlaid spectrum signals of diclofenac sodium and lidocaine hydrochloride. Green Anal Chem. 2025;13:100265. https:\/\/doi.org\/10.1016\/j.greeac.2025.100265.","journal-title":"Green Anal Chem"},{"key":"1803_CR42","doi-asserted-by":"publisher","first-page":"123844","DOI":"10.1016\/j.saa.2024.123844","volume":"309","author":"OM El-Abassy","year":"2024","unstructured":"El-Abassy OM, Maged K, El-Henawee MM, Abd El-Hay SS. Development of eco-friendly spectrophotometric methods for analysis of metformin hydrochloride and linagliptin in presence of metformin toxic impurity in their pure and dosage forms: Validation, practicality and greenness studies. Spectrochim Acta Mol Biomol Spectrosc. 2024;309:123844. https:\/\/doi.org\/10.1016\/j.saa.2024.123844.","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"key":"1803_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41598-025-06157-9;SUBJMETA","volume":"15","author":"OM El-Abassy","year":"2025","unstructured":"El-Abassy OM, Saleh H, Darwish IM, Bahgat EA. Eco-friendly spectrophotometric quantification of the potential combination of mirabegron and tamsulosin. Sci Rep. 2025;15:1\u201311. https:\/\/doi.org\/10.1038\/S41598-025-06157-9;SUBJMETA.","journal-title":"Sci Rep"},{"key":"1803_CR44","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1038\/s41598-025-86070-3","volume":"15","author":"OM El-Abassy","year":"2025","unstructured":"El-Abassy OM, Fawzy MG, Kamel EB. Two chromatographic methods for analyzing paracetamol in spiked human plasma with its toxic metabolite, N-acetyl parabenzoquinone imine and its antidote, N-acetyl-l-cysteine. Sci Rep. 2025;15:4119. https:\/\/doi.org\/10.1038\/s41598-025-86070-3.","journal-title":"Sci Rep"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-026-01803-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01803-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01803-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:22:12Z","timestamp":1783603332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13065-026-01803-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1803"],"URL":"https:\/\/doi.org\/10.1186\/s13065-026-01803-3","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}